IDEXo — Idex Biometrics ASA Cashflow Statement
0.000.00%
TechnologyHighly SpeculativeSmall Cap
- NOK663.57m
- NOK661.52m
- $0.25m
Annual cashflow statement for Idex Biometrics ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -32.5 | -32.7 | -26.6 | -14.6 | -10 |
| Depreciation | |||||
| Non-Cash Items | 3.2 | 2.35 | 1.33 | -8.46 | -1.16 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.07 | -2.37 | -3.33 | 2.97 | 2.13 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -27.5 | -31.4 | -27 | -17.5 | -8.6 |
| Capital Expenditures | -0.141 | -0.267 | -0.243 | — | -0.044 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.002 | 0.107 | 0.247 | 0.272 | 0.025 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.143 | -0.16 | 0.004 | 0.272 | -0.019 |
| Financing Cash Flow Items | — | — | — | — | 0.018 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 54.1 | 14 | 22.2 | 7.92 | 7.32 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 26.5 | -17.6 | -4.77 | -9.34 | -1.3 |